Yuka Natsuki

New‐onset fulminant type 1 diabetes after severe acute respiratory syndrome coronavirus 2 vaccination: A case report

M. Emoto, T. Shoji, T. Morioka, 2022, Journal of Diabetes Investigation.

New-onset Type 1 Diabetes after COVID-19 mRNA Vaccination

M. Emoto, T. Shoji, T. Morioka, 2022, Internal medicine.

Seronegative Full-house Nephropathy with Crohn's Disease

M. Emoto, K. Mori, A. Tsuda, 2022, Internal medicine.

New‐onset fulminant type 1 diabetes after severe acute respiratory syndrome coronavirus 2 vaccination: A case report

M. Emoto, T. Shoji, T. Morioka, 2022, Journal of diabetes investigation.

New-onset fulminant type 1 diabetes after severe acute respiratory syndrome coronavirus 2 vaccination: A case report

M. Emoto, T. Shoji, T. Morioka, 2022 .

Serum Fibroblast Growth Factor 23 Levels are Associated with Vascular Smooth Muscle Dysfunction in Type 2 Diabetes

M. Emoto, M. Inaba, T. Shoji, 2023, Journal of atherosclerosis and thrombosis.